From Benefit to Infrastructure: The Shift Mexico Is Missing

Years ago, when the World Health Organization published that presenteeism costs employers up to 10 times more than absenteeism, the figure circulated as a statistical curiosity. Today, with corporate health budgets overflowing and a workforce that arrives at the office physically but not emotionally or cognitively, that figure has stopped being a curiosity and has become a structural question: If the hidden cost is 10 times greater than the visible one, what exactly are we measuring when we say we manage the health of our people? 

Recent studies cited by Spring Health and Sapien Labs estimate that untreated mental health issues cost US employers between US$31 and US$51 billion a year in absenteeism and presenteeism alone, without counting the secondary costs of turnover, errors, and disengagement. In the United States, mental health-related leaves of absence grew 300% between 2017 and 2023. In Mexico, according to Buk's "2025 Workplace Burnout Report," 72% of employees reported having experienced burnout in the past year, and 60% of workplace medical consultations correspond to anxiety, stress, depression, and sleep disorders. 

The numbers differ; the conversation is the same. What is changing, and fast, is how that conversation is being framed outside of Mexico. Corporate health is migrating from being a benefit administered by human resources departments to being a category of operational infrastructure decided at the CFO's table and at the board level. 

The Global Shift Mexico Is Not Yet Seeing

In March 2026, Forbes spelled it out without ambiguity: workplace well-being is moving from programs to infrastructure. In April, WorldatWork articulated it in terms already standard in rewards conversations in the United States and Europe: Leading organizations are moving from treating well-being as a benefit to treating it as infrastructure. The Global Wellness Institute confirmed it midyear with evidence that well-being is being incorporated into board governance and financial strategy as a measurable variable of value creation. 

The most compelling data comes from the "2027 Employer Healthcare Strategy Survey" by Business Group on Health, published a few weeks ago. Ninety-two percent of large US employers will implement at least one value-based strategy in 2027. Eighty-four percent will offer at least one Center of Excellence. One-third will have an advanced primary care strategy. And 39% are exploring full alternative health plans over the next three years. This is not HR language. It is finance language. It is the same logic applied to spending on technology, cybersecurity, or real estate. And it reflects something simple: When health spending grows 9.5% per year in the United States and 14.8% in Mexico, treating it as a budget line isolated from the rest of the balance sheet is no longer sustainable. 

In this space, I have written before about who pays for health in Mexico (the employer) and about how the system has to learn to reach the patient rather than wait for the patient to arrive. This is the chapter that was missing: where that health lives, inside the organization that finances it.

What Changes When Health Is Infrastructure

The difference between benefit and infrastructure is not semantic. It changes who decides, with what data, against what metrics, and with what expectations. A benefit is decided by the human resources department, competes with meal vouchers and corporate gyms, is justified by adoption and satisfaction, and is measured by number of consultations. Infrastructure is decided by the finance department and by the CEO, competes with investment in technology and cybersecurity, is justified by operational impact, and is measured by risk reduction, business continuity, and value creation. 

A benefit is opt-in. Infrastructure is opt-out. A benefit is sold to the employee with internal marketing. Infrastructure is simply there, like air conditioning or the corporate network. A benefit is contracted annually, with coverage logic. Infrastructure is contracted with architectural logic, with three-to-five-year horizons, with integration to other systems, with metrics of availability and performance. 

This conceptual change is what lies behind the 84% of large companies that will have Centers of Excellence in 2027. 

A Center of Excellence is not just another benefit, it is a clinical architecture selected for its ability to generate better outcomes in specific conditions, integrated into the employee's journey, and measured by outcomes. And this is the important part for the Mexican reader. This shift does not require spending more. It requires spending differently, and above all, deciding differently. It requires the health conversation to leave the benefits committee and reach the operations or executive committee. It requires the CFO to stop seeing health as an opaque expense and start seeing it as an investment with modelable return. 

Mexico Has the Ingredients, Not the Conversation

Mexico has all the ingredients to make this shift before many other emerging markets, but for now almost no company is articulating it that way. The country's numbers support the thesis clearly. Projected medical inflation for 2026 is 14.8% according to Aon, the highest in the world. Major medical insurance premiums rose between 20% and 40% in the first months of the year, and AMASFAC warned that up to 3 million people could cancel their coverage. 

Mexican households contribute 45.4% of total health spending, according to INEGI, and that spending grew 41.4% in real terms between 2018 and 2024. Mexico ranks second among OECD countries for out-of-pocket health spending. 

In parallel, the evidence of operational deterioration accumulates. Seventy-two percent burnout in the workforce, according to Buk. Sixty percent of workplace consultations dedicated to anxiety, stress, depression, and sleep. Only 27% of companies conduct formal psychosocial risk evaluations, according to the STPS, despite NOM-035 having been in force for years. And 60% of people affiliated with a public health institution end up being treated at pharmacies or private clinics, with the cost coming out of the employee's own pocket. 

Each of those numbers is a silent charge to the P&L of a Mexican company. Absenteeism. Presenteeism. Turnover. Errors. Safety incidents. Labor litigation. Loss of knowledge. Replacement cost, which recent studies place between 1.5 and 2 times the annual salary of the departing employee. None of those costs appears in the health benefits line of the budget. All are direct consequences of treating health as a benefit and not as infrastructure. T

Mexican CFOs building the 2027 budget have, at this moment, two options. They can continue allocating the health budget as a function of headcount and policy renewal, and absorb medical inflation as a sunk cost. Or they can start asking which components of their company's health are critical infrastructure, which are optional, and what metrics will tell them whether that infrastructure is delivering value. It is the same question they asked 20 years ago about technology, 10 years ago about data, and five years ago about cybersecurity. Every time the answer was to treat it as infrastructure, the company that moved first captured lasting operational advantage. 

The Regulation Approaching From Outside

There is a force that will accelerate this shift, and it comes from outside. Global frameworks for psychosocial risk and human capital reporting are starting to reach Mexico through the multinationals operating here and through value chains connected to the European market. ISO 45003, the international standard for managing psychosocial risk at work, is being referenced more and more in global corporate governance. In practical terms, it is the conversation NOM-035 opened in Mexico, but with audit teeth and expectations of reporting to the board. 

Mexican companies that supply European firms will start receiving questions about this in their vendor management processes. The European Corporate Sustainability Reporting Directive, in turn, already requires thousands of companies to report human capital and well-being metrics as part of their non-financial statements, and that obligation extends to their subsidiaries and relevant suppliers globally. For Mexican companies, the window is short. Adopting the infrastructure framework now, before it becomes an expectation imposed from outside, allows building calmly what will otherwise have to be built under pressure. 

Where Health Lives Inside the Company

In this space, I have written three chapters of the same conversation. The first was about why the Mexican employer will be the one to redefine corporate health in the country. The second was about why that redefinition passes through changing the premise and bringing health to where the patient already is, rather than waiting for the patient to arrive. This third closes the line: When corporate health is thought of as operational infrastructure and not as a benefit, everything else falls into place. The budget is decided differently. The provider is chosen differently. The metric is built differently. The conversation with the insurer, with the pharmaceutical company, with the government, is sustained differently. 

At diagnostikare.® we have operated under this premise from day one, and what we observe is consistent with what global evidence is beginning to document: close to 9 out of 10 of our users access a medical or psychological consultation for the first time in their lives through our platform. That data is not a marketing achievement. It is the evidence of what it means, in practice, to treat health as infrastructure and not as a benefit. 

The question for 2027 is not how much to spend on health. It is where that health lives inside the company. And the answer to that question will define, more than we imagine today, the operational resilience of Mexican organizations in the coming decade.